1¿ù 13ÀÏ ¿ù¿äÀÏ
¾ÆÀ̵ð
ºñ¹Ð¹øÈ£
¾ÆÀ̵ð ã±â
Ƽ¼ÅÃ÷ (¹ÝÆÈ)
Ƽ¼ÅÃ÷ (±äÆÈ)
Ä¿Ç÷è (ÇÒÀÎ)
Á¡ÆÛ(ÆǸŸ¶°¨)
Ư°¡ÆǸŠ<==ÁøÇàÁß
ºþ¦¼¼ÀÏ
-Ä«µå°áÁ¦¿ë-
Home
> ¹®ÀÇ °Ô½ÃÆÇ ¼öÁ¤
°³ÀÎÁ¤º¸ À¯ÃâÀ» ¹æÁöÇϱâ À§ÇÏ¿© E-Mail°ú ÀüȹøÈ£´Â ÇØ´ç¶õ¿¡ ±âÀçÇÏ¿© ÁÖ½Ã¸é °¨»çÇÏ°Ú½À´Ï´Ù.
À̸§
*
*
´Â ¹Ýµå½Ã ÀÔ·ÂÇØ ÁֽʽÿÀ.
Æнº¿öµå
*
¼öÁ¤, »èÁ¦½Ã¿¡ ÇÊ¿äÇÕ´Ï´Ù.
E-Mail
*
°ø°³ÇÏÁö ¾Ê½À´Ï´Ù.
ÀüȹøÈ£
°ø°³ÇÏÁö ¾Ê½À´Ï´Ù.
Á¦¸ñ
*
³»¿ë
*
There's a three month trial period http://vcreme.edu.vn/order-alli.pdf cliffs pre cheap alli attitude changing Other pharmaceutical companies including Pfizer,Bristol-Myers Squibb Co and Gilead Sciences Inc have also been evaluating a deal, though it remains unclear ifthose parties will proceed with offers given Onyx's richvaluation - with a market value of nearly $10 billion, thepeople said.
¸ñ·Ï
»ç¾÷ÀÚµî·Ï¹øÈ£: 607-10-79364 ºÎ°¡Åë½Å»ç¾÷½Å°í : ºÎ»ê Á¦ 455È£
Copyright (C) 2001 Å©¸®¿¡ÀÌƼºê µðÁöÅÐ All rights reserved.